The urine albumin creatine ratio has been widely used as a conventional biomarker for the onset of DKD and its progression to end-stage renal disease, but there are some differences between the clinical manifestations and histopathological damage of DKD. This evidence concerns the gene ALB and diabetic kidney disease.